The use of MDMA as a treatment for post-traumatic stress disorder (PTSD) has been rejected by a U.S. Food and Drug Administration (FDA) committee following recent trials. The decision was made at an ...

WASHINGTON (AP) — Federal health regulators are questioning the safety and evidence behind the first bid to use MDMA, the mind-altering club drug, as a treatment for PTSD, part of a decadeslong effort ...

The US Food and Drug Administration has been asked to review MDMA, or midomafetamine, the active ingredient in street drugs like ecstasy and molly, along with therapy as a treatment for post-traumatic ...

The independent panel casted doubt on MDMA being a safe and effective treatment. A panel of independent advisers for the U.S. Food and Drug Administration voted against recommending approval of ...

WASHINGTON (AP) — A first-of-a-kind proposal to begin using the mind-altering drug MDMA as a treatment for PTSD was roundly criticized Tuesday — a potentially major setback to psychedelic advocates ...

The Food and Drug Administration declined Friday to approve an application to treat post-traumatic stress disorder using the drug midomafetamine, also known as MDMA or the street drug ecstasy, citing ...

In what could be a pivotal moment for the future of psychedelic medicine, the Food & Drug Administration (FDA) is weighing a decision to approve MDMA-AT, also known as ecstasy or molly, to treat ...

A federal advisory committee on Tuesday voted overwhelmingly against of the use of MDMA, commonly known as ecstasy, as a treatment for post-traumatic stress disorder. The novel treatment has the ...